Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY:CVS)

73.32 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Sep 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Federal Reserve on the Brink: What to Expect from the September Interest Rate Decision
As the financial world braces for the highly anticipated Federal Open Market Committee (FOMC) meeting on September 16-17, 2025, market participants are largely anticipating a significant shift in... 
Via MarketMinute
Topics Artificial Intelligence Bonds Credit Cards
Are Markets Open On Labor Day? Here's What's Open And What's Closed On September 1
Are markets open on Labor Day 2025? Learn what's open and closed on Sept 1, from stocks to stores. Plan your holiday with our guide! 
Via Benzinga
CVS Health Reportedly Keeps Gilead’s New HIV Preventative Shot Off Its Plans, Faces $290M Medicare Fraud Ruling
Via Stocktwits
Topics Fraud
Health Insurance Providers Stocks Q2 In Review: Clover Health (NASDAQ:CLOV) Vs Peers
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks,... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Hanley Investment Group Arranges $12.45 Million Sale of Grocery/Drug-Anchored Center in Philadelphia Metro to California Exchange Buyer
Via AB Newswire
3 Spectacular Stocks You Can Buy Now and Hold Forever
The ultimate long-term investing strategy is buying stocks and holding them forever. 
Via The Motley Fool
Stock Market Today: Walgreens Stock Edges Lower as Buyout Nears
Walgreens Boots Alliance shares slipped slightly on Tuesday as investors adjusted positions ahead of its planned private equity deal. 
Via The Motley Fool
Topics Stocks
S&P 500 Losers: 22 Stocks With Negative Returns Over Past 10 Years, And This One's Getting The Boot
The S&P 500 Index is up over 200% over the past decade, but 22 stocks have declined during that period, and one is set to be removed soon. 
Via Benzinga
Topics Stocks
3 Inflated Stocks We’re Skeptical Of
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a new product line, constructive news flow, or... 
Via StockStory
Topics Cannabis
2 Safe Dividend Stocks to Buy Now That Could Help You Protect and Grow Your Wealth
These low-risk stocks can provide you with reliable and steadily growing passive income. 
Via The Motley Fool
Gilead Sciences' 99.9% Effective HIV Treatment Notches Another Win
The drug is soon to launch in Europe with a new name and a big potential market. 
Via Investor's Business Daily
Small-Cap Stocks Spotlight: KULR, SNYR, RR, IQST Leading Innovation – More Stocks Inside
Via AB Newswire
Topics Artificial Intelligence Regulatory Compliance
Gildea's Kite Pharma Just Acquired Interius—$350 Million Move Shakes Up Cancer Therapy
Kite Pharma is acquiring Interius BioTherapeutics for $350 million, adding in vivo CAR T technology that could simplify treatment and expand patient access. 
Via Benzinga
Gilead Topples On A Surprise Setback For Its 99.9% Effective HIV Drug
Insurance coverage is key for any new drug. But it's looking tenuous for Gilead Sciences' newest HIV prevention drug. 
Via Investor's Business Daily
CVS Health Declines To Add Gilead's Steeply Priced New HIV Prevention Drug To Its Plans
CVS rejected coverage of Gilead's new HIV prevention drug Yeztugo, citing regulatory and financial factors, while facing nearly $290 million in Medicare overcharge penalties. 
Via Benzinga
Q2 Earnings Highlights: Humana (NYSE:HUM) Vs The Rest Of The Health Insurance Providers Stocks
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at health insurance providers stocks,... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Winners And Losers Of Q2: Elevance Health (NYSE:ELV) Vs The Rest Of The Health Insurance Providers Stocks
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at Elevance Health (NYSE:ELV) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Berkshire's UnitedHealth Bet Highlights Long-Term Confidence Despite Depressed Earnings
Michael Burry and Warren Buffett invested in UnitedHealth, signaling confidence in its sector and potential for earnings recovery by 2027. 
Via Benzinga
Synergy Corp. (NASDAQ: SNYR) 1,600+ Nationwide Store Rollout – PPCB, SNGX, BTAI, HIT + Other Disruptive Stocks Moving Now!
Via AB Newswire
Topics Artificial Intelligence
This CVS Health Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
 
Via Benzinga
Wondering what's happening in today's S&P500 pre-market session?
Before the opening bell on Monday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session. 
Via Chartmill
Costco Refuses To Stock Abortion Pill Mifepristone, Pointing To 'Low Demand' As Activist Groups Step Up Pressure On Retail Giants
Costco won't sell abortion pill mifepristone in U.S. stores due to low demand amid pressure from religious groups. 
Via Benzinga
Topics Religion
Corporate Crossroads: Government Eyes Intel Stake as Buffett Bets on Healthcare Giant
In a striking display of market intervention and strategic investment, two major corporate developments are sending ripples through the financial world. The U.S. government is reportedly considering an... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
Inflation's Conundrum: Surging Producer Prices Clash with Steady Consumer Costs, Fueling Rate Uncertainty
The financial markets are grappling with a perplexing economic puzzle as recent inflation data presents a contradictory picture. July 2025 saw the Producer Price Index (PPI) surge significantly,... 
Via MarketMinute
Topics Economy Energy Supply Chain
Get insights into the top movers in the S&P500 index of Friday's pre-market session.
As the US market prepares to open on Friday, let's get an early glimpse into the pre-market session and identify the S&P500 stocks leading the pack in terms of gains and losses. 
Via Chartmill
Health Insurance Providers Stocks Q2 Recap: Benchmarking Cigna (NYSE:CI)
Looking back on health insurance providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Cigna (NYSE:CI) and its peers. 
Via StockStory
Topics Artificial Intelligence Economy Fraud
Q2 Earnings Highlights: AMN Healthcare Services (NYSE:AMN) Vs The Rest Of The Healthcare Providers & Services Stocks
As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare providers & services industry, including AMN Healthcare Services... 
Via StockStory
Synergy Corp (NASDAQ: SNYR) “FOCUSfactor” Q2 +125% YoY Growth, 10th Consecutive Profitable Quarter – More Stocks Inside
Via AB Newswire
Assessing CVS Health: Insights From 6 Financial Analysts
 
Via Benzinga
Health Insurance Providers Stocks Q2 Teardown: Cencora (NYSE:COR) Vs The Rest
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Cencora (NYSE:COR) and the rest... 
Via StockStory
Topics Artificial Intelligence Economy Fraud
< Previous 1 2 3 4 5 6 7 8 9
...
60 61 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.